Kentaro Nakashima

1.1k citations
51 papers · 771 indexed · h-index 14

Kentaro Nakashima

47 papers receiving 763 citations

Peers

Kentaro Nakashima
Comparison fields: 5 of 96
  • Infectious Diseases 155
  • Pulmonary and Respiratory Medicine 206
  • Epidemiology 216
  • Oncology 162
  • Hematology 56
Replace Masashi Matsuyama with:
Masashi Matsuyama Japan
Abdulrahman Aljebreen Saudi Arabia
Edy Y. Kim United States
Joe L. Hsu United States
Zhiyi He China
G. Bresci Italy
Masakazu Okamoto United States
Jürgen Steinhoff Germany
S Dattagupta India
Paolo Pierani Italy
Kentaro Nakashima relative to Masashi Matsuyama Japan Masashi Matsuyama's profile →
Citations per field
00.5×3.0×
Masashi Matsuyama · 1×
Citations per year

Countries citing papers authored by Kentaro Nakashima

Since Specialization
Citations

This map shows the geographic impact of Kentaro Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Nakashima more than expected).

Fields of papers citing papers by Kentaro Nakashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Nakashima. The network helps show where Kentaro Nakashima may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kentaro Nakashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kentaro Nakashima Line = papers co-authored together Kentaro Nakashima links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20241
4 20234
5 20222
6 20214
7 20216
8 20202
9 202012
10 202019
11 202011
12 20191
13 201834
14 20173
15 201715
16 201630
17 20154
18 201225
19 20091
20 20015

About Kentaro Nakashima

Kentaro Nakashima is a scholar working on Hematology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 771 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (9 papers), Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Infectious Diseases (155 citations), Pulmonary and Respiratory Medicine (206 citations) and Epidemiology (216 citations). Kentaro Nakashima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takeshi Kaneko, Nobuyuki Horita, Yuji Shibata, Kenjiro Nagai, Takashi Sato, Masaki Yamamoto, Hiroki Watanabe, Hideyuki Nagakura, Ken Tashiro and Ryota Ushio. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026